✦ LIBER ✦

Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumours

✍ Scribed by A. Awada; F.A.L.M. Eskens; M. Piccart; D.L. Cutler; A. van der Gaast; H. Bleiberg; J. Wanders; M.N. Faber; P. Statkevich; P. Fumoleau; J. Verweij

Book ID: 117659102
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 192 KB
Volume: 38
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(02)00379-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I and pharmacological study of dai

Phase I and pharmacological study of daily oral administration of perifosine (D-21266) in patients with advanced solid tumours

✍ M Crul; H Rosing; G.J de Klerk; R Dubbelman; M Traiser; S Reichert; N.G Knebel; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 127 KB

92 A phase I, pharmacological and biolog

92 A phase I, pharmacological and biological study of Sarasar® (Ionafarnib, SCH 66336), cisplatin and gemcitabine in patients with advanced solid tumors

✍ L. Gore; M. Basche; S.N. Holden; C. O'Bryant; M.K. Schultz; S. Grolnic; M. Morro 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 295 KB

Phase I and pharmacological study of the

Phase I and pharmacological study of the farnesyltransferase inhibitor tipifarnib (Zarnestra®, R115777) in combination with gemcitabine and cisplatin in patients with advanced solid tumours

✍ Siegel-Lakhai, W S; Crul, M; Zhang, S; Sparidans, R W; Pluim, D; Howes, A; Solan 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 121 KB

Phase I and pharmacological study of the

Phase I and pharmacological study of the broad-spectrum tyrosine kinase inhibitor JNJ-26483327 in patients with advanced solid tumours

✍ Konings, I R H M; de Jonge, M J A; Burger, H; van der Gaast, A; van Beijsterveld 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 302 KB

A phase I and pharmacological study of t

A phase I and pharmacological study of the matrix metalloproteinase inhibitor BB-3644 in patients with solid tumours

✍ Wall, L; Talbot, D C; Bradbury, P; Jodrell, D I 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 94 KB

Phase I and pharmacologic study of the m

Phase I and pharmacologic study of the macromolecular topoisomerase-I-inhibitor DE-310 given once every 2 or 6 weeks in patients with solid tumors

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 134 KB